{
  "id": "CVE-2015-3965",
  "assigner": "ics-cert@hq.dhs.gov",
  "Published": "2019-03-23T19:29:00.193Z",
  "Modified": "2019-03-25T18:06:55.39Z",
  "last-modified": "2019-03-25T18:06:55.39Z",
  "summary": "Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger \"unanticipated operations\" by leveraging \"elevated privileges\" for an unspecified call to an incorrectly exposed function.",
  "access": {
    "authentication": "SINGLE",
    "complexity": "LOW",
    "vector": "NETWORK"
  },
  "impact": {
    "availability": "COMPLETE",
    "confidentiality": "COMPLETE",
    "integrity": "COMPLETE"
  },
  "cvss": 9.0,
  "exploitabilityScore": 8.0,
  "impactScore": 10.0,
  "cvss-vector": "AV:N/AC:L/Au:S/C:C/I:C/A:C",
  "references": [
    "https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01"
  ],
  "vulnerable_configuration": [
    "cpe:2.3:o:pfizer:symbiq_infusion_system_firmware:3.13:*:*:*:*:*:*:*"
  ],
  "vulnerable_product": [
    "cpe:2.3:o:pfizer:symbiq_infusion_system_firmware:3.13:*:*:*:*:*:*:*"
  ],
  "vendors": [
    "pfizer"
  ],
  "products": [
    "symbiq_infusion_system_firmware"
  ],
  "vulnerable_product_stems": [
    "cpe:2.3:o:pfizer:symbiq_infusion_system_firmware"
  ],
  "vulnerable_configuration_stems": [
    "cpe:2.3:o:pfizer:symbiq_infusion_system_firmware"
  ],
  "cwe": "CWE-264",
  "vulnerable_configuration_cpe_2_2": []
}